157 related articles for article (PubMed ID: 35307453)
1. Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function.
Xue D; Yang P; Yang Y; Wang Y; Wu K; Qi D; Wang S
Food Chem Toxicol; 2022 May; 163():112921. PubMed ID: 35307453
[TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate alleviates deoxynivalenol-induced porcine intestinal barrier disruption by promoting mitochondrial homeostasis via PCK2 signaling.
Xue D; Cheng Y; Pang T; Kuai Y; An Y; Wu K; Li Y; Lai M; Wang B; Wang S
J Hazard Mater; 2023 Oct; 459():132013. PubMed ID: 37467604
[TBL] [Abstract][Full Text] [Related]
3. Effects of Deoxynivalenol and Mycotoxin Adsorbent Agents on Mitogen-Activated Protein Kinase Signaling Pathways and Inflammation-Associated Gene Expression in Porcine Intestinal Epithelial Cells.
Yu YH; Lai YH; Hsiao FS; Cheng YH
Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922863
[TBL] [Abstract][Full Text] [Related]
4. PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets.
Li E; Li C; Horn N; Ajuwon KM
Toxicol Lett; 2023 Feb; 375():8-20. PubMed ID: 36596350
[TBL] [Abstract][Full Text] [Related]
5. EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPARγ dependent and independent pathways in jejunal IPEC-J2 cells.
Li E; Horn N; Ajuwon KM
Food Res Int; 2022 Jul; 157():111420. PubMed ID: 35761666
[TBL] [Abstract][Full Text] [Related]
6. Deoxynivalenol triggers porcine intestinal tight junction disorder: Insights from mitochondrial dynamics and mitophagy.
Zhang C; Zhang KF; Chen FJ; Chen YH; Yang X; Cai ZH; Jiang YB; Wang XB; Zhang GP; Wang FY
Ecotoxicol Environ Saf; 2022 Dec; 248():114291. PubMed ID: 36395652
[TBL] [Abstract][Full Text] [Related]
7. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.
Diesing AK; Nossol C; Dänicke S; Walk N; Post A; Kahlert S; Rothkötter HJ; Kluess J
PLoS One; 2011 Feb; 6(2):e17472. PubMed ID: 21364771
[TBL] [Abstract][Full Text] [Related]
8. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.
Springler A; Hessenberger S; Schatzmayr G; Mayer E
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27618100
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory injury of porcine small intestinal epithelial cells induced by deoxynivalenol is related to the decrease in glucose transport.
Tang X; Zeng Y; Xiong K; Li M
J Anim Sci; 2024 Jan; 102():. PubMed ID: 38619320
[TBL] [Abstract][Full Text] [Related]
10. Deoxynivalenol induced intestinal barrier injury, mitochondrial dysfunction and calcium overload by inositol 1,4,5-triphosphate receptors (IP3Rs)-mitochondrial calcium uniporter (MCU) calcium axis.
Li X; Gou F; Zhu J; Lin Q; Yu M; Tu X; Hong Q; Hu C
Sci Total Environ; 2024 Feb; 913():169729. PubMed ID: 38160839
[TBL] [Abstract][Full Text] [Related]
11. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
Pinton P; Braicu C; Nougayrede JP; Laffitte J; Taranu I; Oswald IP
J Nutr; 2010 Nov; 140(11):1956-62. PubMed ID: 20861219
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteome Analysis Reveals the Molecular Mechanisms Underlying Deoxynivalenol-Induced Intestinal Toxicity in IPEC-J2 Cells.
Zhang ZQ; Wang SB; Wang RG; Zhang W; Wang PL; Su XO
Toxins (Basel); 2016 Sep; 8(10):. PubMed ID: 27669298
[TBL] [Abstract][Full Text] [Related]
13. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P
Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484
[TBL] [Abstract][Full Text] [Related]
14. Deoxynivalenol, but not E. coli lipopolysaccharide, changes the response pattern of intestinal porcine epithelial cells (IPEC-J2) according to its route of application.
Kluess JW; Kahlert S; Kröber A; Diesing AK; Rothkötter HJ; Wimmers K; Dänicke S
Toxicol Lett; 2015 Dec; 239(3):161-71. PubMed ID: 26417708
[TBL] [Abstract][Full Text] [Related]
15. Nontoxic-dose deoxynivalenol aggravates lipopolysaccharides-induced inflammation and tight junction disorder in IPEC-J2 cells through activation of NF-κB and LC3B.
Ge L; Lin Z; Le G; Hou L; Mao X; Liu S; Liu D; Gan F; Huang K
Food Chem Toxicol; 2020 Nov; 145():111712. PubMed ID: 32877744
[TBL] [Abstract][Full Text] [Related]
16. Deoxynivalenol and its metabolite deepoxy-deoxynivalenol: multi-parameter analysis for the evaluation of cytotoxicity and cellular effects.
Springler A; Hessenberger S; Reisinger N; Kern C; Nagl V; Schatzmayr G; Mayer E
Mycotoxin Res; 2017 Feb; 33(1):25-37. PubMed ID: 27817099
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases.
Pinton P; Tsybulskyy D; Lucioli J; Laffitte J; Callu P; Lyazhri F; Grosjean F; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Sci; 2012 Nov; 130(1):180-90. PubMed ID: 22859312
[TBL] [Abstract][Full Text] [Related]
18. Selenium nanoparticles alleviate deoxynivalenol-induced intestinal epithelial barrier dysfunction by regulating endoplasmic reticulum stress in IPEC-J2 cells.
Song X; Qiao L; Dou X; Chang J; Zhang Y; Xu C
Toxicology; 2023 Aug; 494():153593. PubMed ID: 37442268
[TBL] [Abstract][Full Text] [Related]
19. Effects of hesperidin on mitochondrial function, mitochondria-associated endoplasmic reticulum membranes and IP3R-MCU calcium axis in the intestine of piglets exposed to deoxynivalenol.
Li X; Lin Q; Gou F; Zhu J; Yu M; Hong Q; Hu C
Food Funct; 2024 Jun; 15(12):6459-6474. PubMed ID: 38804659
[TBL] [Abstract][Full Text] [Related]
20. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
